Renascience Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	3,402	1,799	2,026	2,212	2,386
Cash & Short-Term Investments	3,402	1,799	2,026	2,212	2,386
Cash Growth	89.11%	-11.20%	-8.41%	-7.29%	132.78%
Accounts Receivable	-	-	4	-	-
Other Receivables	10	17	-	-	-
Receivables	10	17	4	-	-
Prepaid Expenses	52	42	29	29	31
Other Current Assets	39	13	27	26	11
Total Current Assets	3,503	1,871	2,086	2,267	2,428
Property, Plant & Equipment	-	-	-	4	3
Long-Term Investments	-	-	2	2	6
Other Long-Term Assets	-	-	-	1	1
Total Assets	3,503	1,871	2,088	2,274	2,438
Accounts Payable	-	1	-	-	-
Accrued Expenses	20	1	2	2	2
Current Income Taxes Payable	154	144	123	97	35
Other Current Liabilities	6	5	1	1	-
Total Current Liabilities	180	151	126	100	37
Long-Term Debt	-	-	356	309	199
Other Long-Term Liabilities	1	-	-	-	2
Total Liabilities	181	151	482	409	238
Common Stock	1,982	1,036	1,036	1,036	1,036
Additional Paid-In Capital	2,464	1,518	1,518	1,518	1,518
Retained Earnings	-1,136	-835	-948	-690	-354
Comprehensive Income & Other	12	1	-	1	-
Shareholders' Equity	3,322	1,720	1,606	1,865	2,200
Total Liabilities & Equity	3,503	1,871	2,088	2,274	2,438
Total Debt	-	-	356	309	199
Net Cash (Debt)	3,402	1,799	1,670	1,903	2,187
Net Cash Growth	89.11%	7.72%	-12.24%	-12.99%	297.64%
Net Cash Per Share	264.17	141.52	131.38	149.70	192.03
Filing Date Shares Outstanding	13.33	12.71	12.71	12.71	12.69
Total Common Shares Outstanding	13.33	12.71	12.71	12.71	12.69
Working Capital	3,323	1,720	1,960	2,167	2,391
Book Value Per Share	249.27	135.31	126.34	146.72	173.40
Tangible Book Value	3,322	1,720	1,606	1,865	2,200
Tangible Book Value Per Share	249.27	135.31	126.34	146.72	173.40